An ALLG Window study of Acalabrutinib plus Rituximab followed by R-DHAOx+ASCT in fit Mantle Cell Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date28/01/21 → 27/01/26

Keywords

  • clinical trial
  • lymphoma
  • treatment efficacy
  • treatment safety